Product image of Nimm (Nimesulide) supplied by GNH India

Nimm

Active Ingredient:
Nimesulide
Origin:
EU

Nimm (Nimesulide)

Nimesulide, the active ingredient in Nimm, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for oral use. It is employed to relieve pain, reduce fever, and manage inflammation in adult patients. The medication is indicated for conditions such as osteoarthritis, dysmenorrhea, and acute musculoskeletal pain.

GNH India supplies Nimm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide, with consistent quality standards and research institutions.

Manufacturer / TM Owner

Codal Synto Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nimesulide acts on inflammatory pathways to provide analgesic, antipyretic and anti‑inflammatory effects.

  • Acute pain: Reduces discomfort associated with short‑term musculoskeletal injuries.
  • Fever: Lowers elevated body temperature in febrile conditions.
  • Osteoarthritis: Improves joint pain and functional mobility in chronic degenerative disease.
  • Dysmenorrhea: Alleviates menstrual cramps and associated pelvic pain.
  • Inflammatory conditions: Controls swelling and tenderness in acute inflammatory states.

How It Works

  • Nimesulide selectively inhibits cyclooxygenase‑2 (COX‑2) enzymes, decreasing the conversion of arachidonic acid to prostaglandins. By reducing prostaglandin synthesis, it diminishes inflammation, pain signaling, and fever generation while sparing COX‑1 activity, which helps maintain gastric mucosal protection.

Side Effects

Nimesulide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain.
  • Headache: mild to moderate intensity.
  • Dizziness or vertigo.
  • Skin rash: mild erythema or itching.
  • Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects

  • Hepatotoxicity: severe liver injury or failure.
  • Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Severe hypersensitivity reactions: anaphylaxis or angioedema.
  • Gastrointestinal bleeding or ulceration.
  • Renal impairment: acute kidney injury.

Precautions & Warnings

Before prescribing Nimesulide, clinicians should evaluate patient history and monitor specific parameters.

  • Assess liver function: perform baseline hepatic enzyme tests and monitor periodically.
  • Evaluate renal status: check kidney function in patients with pre‑existing renal disease.
  • Review cardiovascular risk: avoid use in patients with uncontrolled hypertension or heart failure.
  • Check for gastrointestinal history: use cautiously in those with ulcer disease or bleeding tendencies.
  • Avoid in patients with known hypersensitivity to NSAIDs: discontinue at first sign of allergic reaction.
  • Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Nimesulide can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Anticoagulants (e.g., warfarin): increased bleeding risk.
  • Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity.

Moderate Interactions (Monitor Closely)

  • Lithium: Nimesulide may raise lithium serum levels.
  • Methotrexate: potential for enhanced toxicity.
  • Cyclosporine: increased risk of nephrotoxicity.
  • SSRIs (e.g., sertraline): may augment bleeding tendency.
  • Diuretics: possible reduction in antihypertensive effect.

Frequently Asked Questions

Nimm contains Nimesulide, an NSAID indicated for relief of mild to moderate pain, reduction of fever, and control of inflammation associated with conditions such as osteoarthritis, dysmenorrhea and acute musculoskeletal injuries. It is prescribed for adult patients when a selective COX‑2 inhibitor is appropriate.

Nimesulide works by selectively inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which blocks the conversion of arachidonic acid to prostaglandins. This reduction in prostaglandin production diminishes the inflammatory response, lowers pain signaling, and helps normalize elevated body temperature.

The dosage of Nimm is determined by the prescribing healthcare professional based on the patient’s condition, age, weight and renal or hepatic function. Only a qualified prescriber should set the dose and duration of therapy; patients should follow the written prescription exactly.

The safety of Nimesulide in pregnancy and lactation has not been established, and it is generally avoided, especially in the third trimester, due to potential fetal risks. Breastfeeding mothers should consult their physician, as the drug may be excreted in milk.

To order Nimm, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with non‑selective NSAIDs, Nimesulide offers selective COX‑2 inhibition, which may reduce the incidence of gastrointestinal irritation while still providing effective analgesic and antipyretic action. However, it shares similar risks of hepatic effects and should be chosen based on individual patient risk profiles.

Nimm tablets should be stored at ambient temperature below 25 °C, in their original packaging, and protected from moisture and direct sunlight. Do not store in a refrigerator or freezer, and keep out of reach of children.

Nimm is taken orally, usually with a full glass of water. It may be taken with or without food, but taking it with meals can lessen mild gastrointestinal discomfort. Patients should swallow the tablet whole and not split or crush it unless instructed by a healthcare professional.

The most serious adverse reactions to Nimesulide include severe liver injury, such as hepatitis or hepatic failure, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Prompt medical attention is required if signs of jaundice, dark urine, rash, or blistering develop.

Nimm should be avoided in patients with known hypersensitivity to Nimesulide or other NSAIDs, those with active peptic ulcer disease, severe hepatic or renal impairment, uncontrolled hypertension, and in the third trimester of pregnancy. Consultation with a physician is essential before initiating therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Nimesulide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT